the complexity of choosing biosimilars in oncology
Published 4 years ago • 132 plays • Length 5:56Download video MP4
Download video MP3
Similar videos
-
1:48
dr. markman on the concept of biosimilars in oncology
-
5:58
the availability of multiple biosimilars for 1 biologic
-
1:08
dr. tripathy on the progression of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
13:32
01 introduction to biosimilars
-
7:21
biologic drugs and biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
7:22
an overview of biosimilarity
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:41
similarity of biosimilars and biologics
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
9:26
the future direction of biosimilars
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:56
dr. kolberg on ensuring confidence with biosimilars in oncology
-
6:00
quick guide to biosimilars
-
1:53
dr. rugo discusses a comparative review of trastuzumab biosimilars
-
0:47
dr. o'regan discusses biosimilar education in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology